Search
Now showing items 1-6 of 6
Article
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
| Date Issued:
2017 | Copyright:
open access
Article
Emergence of the East-Central-South-African genotype of Chikungunya virus in Brazil and the city of Rio de Janeiro may have occurred years before surveillance detection
| Date Issued:
2019 | Copyright:
open access
Article
An observational clinical case of Zika virus-associated neurological disease is associated with primary IgG response and enhanced TNF levels
| Date Issued:
2018 | Copyright:
restricted access
Article
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
| Date Issued:
2017 | Copyright:
open access
Article
Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
| Date Issued:
2019 | Copyright:
open access
Article
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
| Date Issued:
2019 | Copyright:
open access